Advertisement
Commentary| Volume 62, ISSUE 5, P489-494, May 2009

Download started.

Ok

The practicalists' response

  • Paul J. Karanicolas
    Correspondence
    Corresponding author. Department of Clinical Epidemiology and Biostatistics, McMaster University Medical Center, 1200 Main Street W., Room 2C12, Hamilton, Ontario L8N 3Z5, Canada.
    Affiliations
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

    Department of Surgery, University of Western Ontario, London, Ontario, Canada
    Search for articles by this author
  • Victor M. Montori
    Affiliations
    Knowledge & Encounter Research Unit, College of Medicine, Mayo Clinic, Rochester, MN, USA
    Search for articles by this author
  • P.J. Devereaux
    Affiliations
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Search for articles by this author
  • Holger Schünemann
    Affiliations
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

    Italian National Cancer Institute, Rome/Istituto Regina Elena, Italy
    Search for articles by this author
  • Gordon H. Guyatt
    Affiliations
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Search for articles by this author
      To inform our response to the traditionalist's commentary, we have corresponded directly with Dr. Oxman on email. We would like to thank the traditionalists for this productive interchange. To be most clearly informative to the audience, we will organize our response under areas in which we perceive clear agreement in our viewpoints, areas in which there is partial agreement or in which we are uncertain of the extent of agreement, and areas in which there is clear disagreement. In doing so, we will quote directly from the traditionalist's emails. For points of agreement or possible agreement we will use the terms “pragmatic” and “explanatory.”
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Oxman A.
        • Lombard C.
        • Treweek S.
        • Gagnier J.J.
        • Maclure M.
        • Zwarenstein M.
        Why we will remain pragmatists: four problems with the impractical mechanistic framework and a better solution.
        J Clin Epidemiol. 2009; 62 ([in this issue]): 485-488
        • Schwartz D.
        • Lellouch J.
        Explanatory and pragmatic attitudes in therapeutical trials.
        J Chronic Dis. 1967; 20 ([reprinted in this issue; J Clin Epidemiol 2009;62:499–505].): 637-648
        • Charlton B.G.
        Understanding randomized controlled trials: explanatory or pragmatic?.
        Fam Pract. 1994; 11: 243-244
        • Flay B.R.
        • Biglan A.
        • Boruch R.F.
        • Castro F.G.
        • Gottfredson D.
        • Kellam S.
        • et al.
        Standards of evidence: criteria for efficacy, effectiveness and dissemination.
        Prev Sci. 2005; 6: 151-175
        • Gartlehner G.
        • Hansen R.A.
        • Nissman D.
        • Lohr K.N.
        • Carey T.S.
        A simple and valid tool distinguished efficacy from effectiveness studies.
        J Clin Epidemiol. 2006; 59: 1040-1048
        • Halloran M.E.
        • Struchiner C.J.
        • Longini Jr., I.M.
        Study designs for evaluating different efficacy and effectiveness aspects of vaccines.
        Am J Epidemiol. 1997; 146: 789-803
        • MacRae K.D.
        Pragmatic versus explanatory trials.
        Int J Technol Assess Health Care. 1989; 5: 333-339
        • Fields W.
        • Maslenikov V.
        • Meyer J.
        • Hass W.K.
        • Remington RD.
        • MacDonald M.
        Joint study of extracranial arterial occlusion: progress report on prognosis following surgery or non-surgical treatment for transient ischaemic attacks and cervical carotid artery lesions.
        JAMA. 1970; 211: 1993-2003
        • Shaw D.
        • Venables G.
        • Cartlidge N.
        • Bates D.
        • Dickinson P.H.
        Carotid endarterectomy in patients with transient cerebral ischaemia.
        J Neurol Sci. 1984; 64: 45-53
        • European Carotid Surgery Trialists' Collaborative Group
        Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).
        Lancet. 1998; 351: 1379-1387
        • North American Symptomatic Carotid Endarterectomy Trialists' Collaborative Group
        The final results of the NASCET trial.
        N Engl J Med. 1998; 339: 1415-1425
        • Mayberg M.R.
        • Wilson E.
        • Yatsy F.
        • Weiss D.G.
        • Messina L.
        • Hershey L.A.
        • et al.
        Carotid endarterectomy and prevention of cerebral ischaemia in symptomatic carotid stenosis.
        JAMA. 1991; 266: 3289-3294
        • Rothwell P.M.
        • Eliasziw M.
        • Gutnikov S.A.
        • Fox A.J.
        • Taylor D.W.
        • Mayberg M.R.
        • et al.
        Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.
        Lancet. 2003; 361: 107-116
        • Atkins D.
        • Best D.
        • Briss P.A.
        • Eccles M.
        • Falck-Ytter Y.
        • Flottorp S.
        • et al.
        Grading quality of evidence and strength of recommendations.
        BMJ. 2004; 328: 1490-1494
        • Guyatt G.H.
        • Gutterman D.
        • Baumann M.H.
        • Addrizzo-Harris D.
        • Hylek E.M.
        • Phillips B.
        • et al.
        Grading strength of recommendations and quality of evidence in clinical guidelines.
        Chest. 2006; 129: 174-181
        • Stephenson B.J.
        • Rowe B.H.
        • Haynes R.B.
        • Macharia W.M.
        • Leon G.
        The rational clinical examination. Is this patient taking the treatment as prescribed?.
        JAMA. 1993; 269: 2779-2781